Climb Bio (NASDAQ:CLYM) reported quarterly losses of $(0.13) per share. This is a 13.33 percent increase over losses of $(0.15) per share from the same period last year.
- Headlines
- Climb Bio Q3 EPS $(0.13) Up From $(0.15) YoY
Climb Bio Q3 EPS $(0.13) Up From $(0.15) YoY
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
03:58
Optimizing fiscal "multiplication" to prioritize the issuance of larger-scale government Bonds.
03:55
More than 80% of companies have been surveyed, with the electronics and six other major industries receiving the most attention.
CSI SWS Health Care index+0.98%
03:41
The Israeli military claimed to have destroyed a Hamas rocket launch site in northern Gaza.